BA

Healthcare · Pharmaceuticals

Bal Pharma Ltd (BALPHARMA)

₹83.21

Mkt cap
₹145 Cr
P/E ratio
18.30
P/B
1.52
Div yield
1.32%
ROE
7.79%
ROCE
9.75%
EPS (TTM)
₹4.55
Book value
₹55
52W range
60–125
Sector
Healthcare

Price history

Previous close

Incorporated in 1987, Bal Pharma Ltd does manufacturing and selling of pharmaceutical products and related services [1]

NSE BALPHARMABSE 524824
Health check
Mixed
ValuationCheap
ProfitabilityWeak
GrowthModerate
TechnicalsNeutral
52-week range
−33.22% from high
₹83
₹60+38.68% from low₹125
Current
₹83.21
Prev close
₹84.61
Day
−1.65%
Price performance
1D
−1.96%
1W
−8.79%
1M
−1.92%
3M
−4.28%
6M
−2.56%
1Y
+3.17%
YTD
+13.60%

Financials

Revenue, profit & margin
P/E ratio
18.3×
BALPHARMA is 46% below the sector median of 34.0×
BALPHARMA18.3×
Sector median34.0×
 Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026Trend
Sales92.5481.6694.6374.3673.6973.1581.8865.8774.0287.6984.0888.6289.95
YoY Sales growth+22.88%+6.58%+14.77%+5.64%-20.37%-10.42%-13.47%-11.42%+0.45%+19.88%+2.69%+34.54%+21.52%
Expenses84.8473.8785.0367.8966.0065.4074.2459.8168.2978.1573.5080.6781.29
Operating Profit7.707.799.606.477.697.757.646.065.739.5410.587.958.66
OPM %8.32%9.54%10.14%8.70%10.44%10.59%9.33%9.20%7.74%10.88%12.58%8.97%9.63%
Other Income0.140.102.450.82-0.200.511.080.721.120.33-0.240.441.63
Interest3.823.664.144.243.655.013.954.053.864.854.064.474.98
Depreciation2.422.962.162.432.482.692.182.522.273.233.062.783.38
Profit before tax1.601.275.750.621.360.562.590.210.721.793.221.141.93
Tax %39.38%33.07%3.65%58.06%23.53%7.14%-108.88%0.00%0.00%0.00%-12.11%0.00%25.91%
Net Profit0.970.855.530.261.040.525.410.210.721.793.601.131.43
EPS in Rs0.610.563.460.160.650.303.410.130.451.122.250.700.89
Raw PDF

Earnings

Results dates & reactions
No upcoming results date on calendar.

Fresh quarters land in the Financials table above, tagged NSE until screener catches up.

Avg earnings-day move +1.25% · closed higher next day 1 of last 2
 Q1FY27Q2FY27
Broadcast12 Aug '26◦11 Nov '26◦
Earnings day−2.50%+4.99%
+1 day−3.81%+8.38%
+5 days−4.24%+0.83%
+15 days−3.08%—
+30 days+19.02%—
FilingXBRLXBRL

Corporate actions

Last 6 months

No recent corporate actions

Dividends, splits, and bonuses in the last six months show up here.

Shareholding

as of Sep 2026
50.87%Promoter
Promoters50.87%
FIIs0.28%0.13
Public48.87%0.12
Ownership trend

Peers

8 companies
Valuation vs quality
P/E × ROCE · bubble = market cap
NameCMPP/EMkt CapDiv YldNP QtrQtr Profit VarSales QtrQtr Sales VarROCE
Sun Pharma.Inds.₹1,880.0036.664,51,0750.85%1,995−10.53%16,199+11.88%20.53%
Divi's Lab.₹11,442.0088.893,03,7490.26%1,127+63.57%3,676+35.40%21.97%
Torrent Pharma.₹4,670.0081.821,77,6320.81%534−10.03%4,979+50.79%15.19%
Laurus Labs₹2,424.0097.751,30,9720.08%436+126.43%2,206+33.44%17.76%
Zydus Lifesci.₹1,189.9026.201,18,6930.08%928−27.96%7,910+29.17%21.14%
Dr Reddy's Labs₹1,380.0041.171,15,2670.58%913−31.35%8,698−1.48%13.04%
Cipla₹1,391.8036.211,12,4420.93%852−35.05%7,404−2.44%15.49%
Bal Pharma₹90.9418.301451.32%1+100.00%90+21.52%9.75%
Median: 160 Co.₹465.8333.992,0120.08%13+33.53%179+20.92%14.94%

Filings